Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 46708-455

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 46708-455). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Valsahctz Figur1)

A scatter plot graph depicting the probability of achieving systolic blood pressure (SBP) under 140 mmHg at week 8. The x-axis represents baseline SBP (mmHg) ranging from 140 to 180, while the y-axis shows the percentage achieving the target SBP from 0 to 100%. Four data series compare Valsartan and hydrochlorothiazide tablets 320/25 mg, valsartan 320 mg, hydrochlorothiazide 25 mg, and placebo, with the combination showing the highest probability across baseline SBP values.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Three line graphs showing probabilities of achieving target blood pressure levels at Week 8 for Valsartan and Hydrochlorothiazide 320/25 mg tablets compared to Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The first graph plots probability of diastolic BP <90 mmHg against baseline diastolic BP (90-110 mmHg). The second shows systolic BP <130 mmHg probability versus baseline systolic BP (140-180 mmHg). The third displays diastolic BP <80 mmHg probability against baseline diastolic BP (90-110 mmHg). Valsartan and hydrochlorothiazide tablets consistently show higher probabilities across all graphs.*

FDA Label Image

Structure (Valsahctz Hctz)

Chemical structure diagram of the active ingredient shown in the image, depicting atomic connections with rings, nitrogen, oxygen, sulfur, chlorine, and sulfonamide groups.*

FDA Label Image

Structure (Valsahctz Valsa)

Chemical structure diagram of Valsartan, one of the active ingredients in the combination drug Valsartan and Hydrochlorothiazide.*

FDA Label Image

30's Bottle Pack (Valsartan Hctz 160125mg)

Label for Valsartan and Hydrochlorothiazide Tablets, USP, showing strength of 160 mg/12.5 mg. The film-coated tablets come in a bottle of 30 count. Label includes storage and dispensing instructions, the National Drug Code (NDC) 46708-454-30, and Alembic Pharmaceuticals Limited as the manufacturer.*

FDA Label Image

30's Bottle Pack (Valsartan Hctz 16025mg)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 160 mg/25 mg, film-coated tablets supplied in a bottle of 30. Label includes storage instructions, manufacturer information (Alembic Pharmaceuticals Limited), dosage form, and a barcode. The product is Rx only.*

FDA Label Image

30's Bottle Pack (Valsartan Hctz 320125mg)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/12.5 mg, film-coated oral tablets. The label includes storage instructions, dosage form, 30 tablet count, and is manufactured by Alembic Pharmaceuticals Limited. The NDC on the label is 46708-456-30, with a barcode and space for lot and expiration information.*

FDA Label Image

30's Bottle Pack (Valsartan Hctz 32025mg)

Label for Valsartan and Hydrochlorothiazide Tablets, USP 320 mg/25 mg film-coated tablets. The label states the product contains 30 tablets and is manufactured by Alembic Pharmaceuticals Limited. It includes storage instructions at 25°C, dosage reference to package insert, and a barcode. The label also notes prescription-only status and advises pharmacists to dispense with patient information leaflets.*

FDA Label Image

30's Bottle Pack (Valsartan Hctz 80125mg)

Label for Valsartan and Hydrochlorothiazide Tablets USP, 80 mg/12.5 mg, film-coated oral tablets by Alembic Pharmaceuticals Limited. The label includes the NDC 46708-453-30, storage instructions, and a 30 tablet package count with directions to dispense with patient information leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.